Lei Lei
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 10, 2023
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer.Ziyan Yang, Jianguo Feng, Ji Jing
|Oct 15, 2021
BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis.Jia-Ni Pan, Lei Lei, Wei-Wu Ye
|Feb 27, 2020
The Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients.Ziyan Yang, Nani Li, Xiaolin Li
|Jan 26, 2020
An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway.Zi-Yan Yang, Liu Yang, Chun-Wei Xu
|Nov 07, 2019
Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center study.Lei Lei, Wen-Xian Wang, You-Cai Zhu
Pageof 1
Frequent Collaborators
3 joint publications
Ziyan Yang
3 joint publications
Xiao-Jia Wang
2 joint publications
Chun-Wei Xu
2 joint publications
Wen-Ming Cao
1 joint publications
Wen-Xian Wang
1 joint publications
Jin-Luan Li
1 joint publications
Yong Song
1 joint publications
Liu Yang
1 joint publications
Nani Li
1 joint publications
Jia-Ni Pan
